Associated tags: Fraud, Wohl, Sale, Security (finance), Wall Street
Locations: NEW YORK, UNITED STATES, TATA, CALIFORNIA, PROSPECT, CALLON, BENCHMARK, GOLDMAN, BLACKSTONE, MONSEY, NY, US, IMO, WALL STREET, MARATHON, KIMMERIDGE
Wall Street,
Comment,
Alpha,
Sale,
IPO,
CPIB,
Silver,
XM,
Diesel,
Wohl,
Seeking Alpha,
L.L.C,
News,
Security (finance),
Audit,
Qualtrics MONSEY, N.Y., March 13, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the $18.15 per share in cash at which Qualtrics International Inc. (Nasdaq: XM) (Qualtrics) will be sold to an investor consortium led by Silver Lake Management Company VI, L.L.C.
Key Points:
- MONSEY, N.Y., March 13, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the $18.15 per share in cash at which Qualtrics International Inc. (Nasdaq: XM) (Qualtrics) will be sold to an investor consortium led by Silver Lake Management Company VI, L.L.C.
- On March 13, 2023, Qualtrics announced that it is being sold to an investor consortium led by Silver Lake and CPIB for $18.15 per share in cash.
- The sale has been approved by the Qualtrics board of directors (Board).
- “We are investigating whether the Qualtrics Board acted in the best interests of Qualtrics shareholders in approving the sale,” explained Joshua Fruchter, one of the law firm’s name partners.
EQ,
Radius Inc.,
Sale,
EQT,
Wohl,
Seeking Alpha,
Comment,
Acquisition,
Wall Street,
Security (finance),
Radius MONSEY, N.Y., March 02, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of Radius Global Infrastructure, Inc. (Nasdaq: RADI) (“Radius”) acted in the best interests of Radius shareholders in approving the sale of Radius to EQT and Public Sector Pension Investment Board (“PSPIB”) for $15.00 per share in cash.
Key Points:
- MONSEY, N.Y., March 02, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of Radius Global Infrastructure, Inc. (Nasdaq: RADI) (“Radius”) acted in the best interests of Radius shareholders in approving the sale of Radius to EQT and Public Sector Pension Investment Board (“PSPIB”) for $15.00 per share in cash.
- On March 1, 2023, after the market closed, Radius announced that it had agreed to be acquired by EQT and PSPIB for $15.00 per share in cash.
- The agreement has been approved by the Radius board of directors (“Board”).
- “We are investigating whether the Radius Board acted in the best interests of Radius shareholders in approving the sale,” explained Joshua Fruchter, one of the law firm’s name partners.
Retrieved on:
Tuesday, February 28, 2023
Wall Street,
ROCC,
Ranger Oil Corporation,
Wohl,
Primary energy,
Sale,
Acquisition,
Fenthion,
Security (finance),
Private investigator,
Ranger MONSEY, N.Y., Feb. 28, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of Ranger Oil Corporation (Nasdaq: ROCC) (“Ranger”) acted in the best interests of Ranger shareholders in approving the acquisition of Ranger by Baytex Energy Corp. (“Baytex”).
Key Points:
- MONSEY, N.Y., Feb. 28, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of Ranger Oil Corporation (Nasdaq: ROCC) (“Ranger”) acted in the best interests of Ranger shareholders in approving the acquisition of Ranger by Baytex Energy Corp. (“Baytex”).
- Under the deal terms, Ranger shareholders will receive a fixed ratio of 7.49 Baytex shares plus $13.31/share in cash for each Ranger common share, for total consideration that Baytex has estimated as $44.36 per Ranger share.
- On February 28, 2023, Ranger announced that it had agreed to be acquired by Baytex for a fixed ratio of 7.49 Baytex shares plus $13.31/share in cash for each Ranger common share, for total consideration that Baytex has estimated as $44.36 per Ranger share.
- “We are investigating whether Ranger’s Board acted in the best interests of Ranger shareholders in approving the sale,” explained Joshua Fruchter, a partner at Wohl & Fruchter.
Retrieved on:
Monday, February 27, 2023
Report of the Special Committee on the Termination of the National Emergency,
Special,
Wohl,
Acquisition,
Stone Point,
FOCS,
CDR,
Sale,
Focus Financial Partners,
Dubilier,
Common stock,
Clayton, Dubilier & Rice,
Bank,
Focus MONSEY, N.Y., Feb. 27, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of Focus Financial Partners, Inc. (Nasdaq: FOCS) (“Focus”) acted in the best interests of Focus shareholders in approving the sale of Focus to Clayton, Dubilier & Rice (“CDR”) for $53.00 per share in cash upon the recommendation of a special committee of purportedly independent directors.
Key Points:
- MONSEY, N.Y., Feb. 27, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of Focus Financial Partners, Inc. (Nasdaq: FOCS) (“Focus”) acted in the best interests of Focus shareholders in approving the sale of Focus to Clayton, Dubilier & Rice (“CDR”) for $53.00 per share in cash upon the recommendation of a special committee of purportedly independent directors.
- On February 27, 2023, Focus announced that it had agreed to be acquired by CDR for $53.00 per share in cash.
- The agreement has been approved by the Focus board of directors (“Board”) upon the recommendation of a special committee of purportedly independent directors.
- “We are investigating whether Focus’s Board acted in the best interests of Focus shareholders in approving the sale,” explained Joshua Fruchter, a partner at Wohl & Fruchter.
Retrieved on:
Wednesday, February 22, 2023
MONSEY, N.Y., Feb. 22, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of INDUS Realty Trust, Inc. (Nasdaq: INDT) (“INDUS”) acted in the best interests of INDUS shareholders in approving the sale of INDUS to Centerbridge Partners and GIC Real Estate (“GIC”) for $67.00 per share in cash.
Key Points:
- MONSEY, N.Y., Feb. 22, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of INDUS Realty Trust, Inc. (Nasdaq: INDT) (“INDUS”) acted in the best interests of INDUS shareholders in approving the sale of INDUS to Centerbridge Partners and GIC Real Estate (“GIC”) for $67.00 per share in cash.
- On February 22, 2023, INDUS announced that it had agreed to be acquired by Centerbridge Partners and GIC for $67.00 per share in cash.
- “We are investigating whether the INDUS Board acted in the best interests of INDUS shareholders in approving the sale,” explained Joshua Fruchter, one of the law firm’s name partners.
- At the time of the article, Centerbridge Partners and GIC had made an opening bid of $65.00 per share in cash, which the author characterized as “low-ball.”
Retrieved on:
Thursday, February 9, 2023
MONSEY, N.Y., Feb. 09, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of Sumo Logic, Inc. (Nasdaq: SUMO) (“SUMO”) acted in the best interests of SUMO shareholders in approving the sale of SUMO to Francisco Partners for $12.05 per share in cash.
Key Points:
- MONSEY, N.Y., Feb. 09, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of Sumo Logic, Inc. (Nasdaq: SUMO) (“SUMO”) acted in the best interests of SUMO shareholders in approving the sale of SUMO to Francisco Partners for $12.05 per share in cash.
- On February 9, 2023, SUMO announced that it had agreed to be acquired by Francisco Partners for $12.05 per share in cash.
- “We are investigating whether SUMO’s Board acted in the best interests of SUMO shareholders in approving the sale,” explained Joshua Fruchter, one of the law firm’s name partners.
- This is above the deal price, which suggests at least one Wall Street analyst thinks the deal price is too low.
Retrieved on:
Thursday, February 9, 2023
MONSEY, N.Y., Feb. 09, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of NuVasive, Inc. (Nasdaq: NUVA) (“NuVasive”) acted in the best interests of NuVasive shareholders in approving the merger of NuVasive with Globus Medical, Inc. (“Globus”) in an all-stock transaction pursuant to which 0.75 shares of Globus will be exchanged for each share of NuVasive.
Key Points:
- MONSEY, N.Y., Feb. 09, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of NuVasive, Inc. (Nasdaq: NUVA) (“NuVasive”) acted in the best interests of NuVasive shareholders in approving the merger of NuVasive with Globus Medical, Inc. (“Globus”) in an all-stock transaction pursuant to which 0.75 shares of Globus will be exchanged for each share of NuVasive.
- The share exchange values NuVasive at $57.72 per share based on Globus’ last close.
- However, Globus’s stock price is down sharply today on the news, which has substantially reduced the value of the deal to NuVasive shareholders.
- “We are investigating whether NuVasive’s Board acted in the best interests of NuVasive shareholders in approving the sale,” explained Joshua Fruchter, a partner in the firm.
Retrieved on:
Thursday, February 9, 2023
MONSEY, N.Y., Feb. 09, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of Cardiovascular Systems, Inc. (Nasdaq: CSII) (“CSII”) acted in the best interests of CSII shareholders in approving the sale of CSII to Abbott Laboratories (“Abbott”) for $20.00 per share in cash.
Key Points:
- MONSEY, N.Y., Feb. 09, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of Cardiovascular Systems, Inc. (Nasdaq: CSII) (“CSII”) acted in the best interests of CSII shareholders in approving the sale of CSII to Abbott Laboratories (“Abbott”) for $20.00 per share in cash.
- On February 9, 2023, CSII announced that it had agreed to be acquired by Abbott for $20.00 per share in cash.
- “We are investigating whether CSII’s Board acted in the best interests of CSII shareholders in approving the sale,” explained Joshua Fruchter, one of the law firm’s name partners.
- Both are above the deal price, which suggests Wall Street analysts think the deal price is too low.
Retrieved on:
Wednesday, February 8, 2023
MONSEY, N.Y., Feb. 08, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of Oak Street Health, Inc. (NYSE: OSH) (“Oak Street”) acted in the best interests of Oak Street shareholders in approving the sale of Oak Street to CVS Health Corporation (“CVS”) for $39.00 per share in cash.
Key Points:
- MONSEY, N.Y., Feb. 08, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of Oak Street Health, Inc. (NYSE: OSH) (“Oak Street”) acted in the best interests of Oak Street shareholders in approving the sale of Oak Street to CVS Health Corporation (“CVS”) for $39.00 per share in cash.
- On February 8, 2023, Oak Street announced that it had agreed to be acquired by CVS for $39.00 per share in cash.
- The agreement has been approved by the Oak Street board of directors (“Board”).
- “Our investigation concerns whether Oak Street’s Board acted in the best interests of Oak Street shareholders in approving the sale,” explained Joshua Fruchter, one of the firm’s name partners.
Retrieved on:
Wednesday, February 8, 2023
NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of Argo Group International Holdings, Ltd. (NYSE: ARGO) (“Argo”) acted in the best interests of Argo shareholders in approving the sale of Argo to Brookfield Reinsurance (“Brookfield”) for $30.00 per share in cash.
Key Points:
- NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of Argo Group International Holdings, Ltd. (NYSE: ARGO) (“Argo”) acted in the best interests of Argo shareholders in approving the sale of Argo to Brookfield Reinsurance (“Brookfield”) for $30.00 per share in cash.
- On February 8, 2023, Argo announced that it had agreed to be acquired by Brookfield for $30.00 per share in cash.
- The agreement has been approved by the Argo board of directors (“Board”).
- “Our investigation concerns whether Argo’s Board acted in the best interests of Argo shareholders in approving the sale,” explained Joshua Fruchter, one of the firm’s name partners.
